Pharmacologic interventions for pregnant women enrolled in alcohol treatment

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Smith, Erica J ^a   Lui, Steve ^b   Terplan, Mishka ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CLOMETHIAZOLE; DISULFIRAM; NALTREXONE; PHENOTHIAZINE DERIVATIVE; PLACEBO;

ALCOHOL CONSUMPTION; ALCOHOLISM; CELL HETEROGENEITY; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DATA SYNTHESIS; DRUG EFFECT; HUMAN; INFORMATION PROCESSING; MEDICAL RESEARCH; META ANALYSIS; MORBIDITY; MORTALITY; PREGNANCY; PSYCHOSOCIAL CARE; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 70049109792     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007361.pub2     Document Type: Review

References (68)

1. Bartu A, Sharp J, Ludlow J, Doherty DA. Postnatal home visiting for illicit drug-using mothers and their infants: a randomised controlled trial. Australian & New Zealand Journal of Obstetrics & Gynaecology 2006;46(5):419-426 (Pubitemid 44309082)
2. Bergman U, Rosa FW, Baum C, Wiholm BE, Faich GA. Effects of exposure to benzodiazepine during fetal life. Lancet 1992;340 (8821):694-696
3. Brewer C. Harm-reduction for unwanted pregnancies and unwanted addictions: an instructive analogy. Adicciones 2008;20(1):5-13.
4. Ferreira E, Carceller AM, Agogue C, Martin BZ, St-Andre M, Francoeur D, et al.Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 2007;119(1):52-59 (Pubitemid 46397842)
5. Flores-Huerta S, Hernandez-Montes H, Argote RM, Villalpando S. Effects of ethanol consumption during pregnancy and lactation on the outcome and postnatal growth of the offspring. Annals of Nutrition & Metabolism 1992;36(3):121-128
6. Fuller RK, Gordis E. Does disulfiram have a role in alcoholism treatment today?[see comment]. [Review] [23 refs]. Addiction 2004;99 (1):21-24
7. Heading CE. Gender issues and the pharmacotherapy of substance abuse. [Review] [8 refs]. Idrugs 2008;11(6):428-432
8. Kanto JH. Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. [Review] [117 refs]. Drugs 1982;23(5):354-380
9. Laegreid L, Hagberg G, Lundberg A. Neurodevelopment in late infancy after prenatal exposure to benzodiazepines - a prospective study. Neuropediatrics 1992;23(2):60-67
10. Laegreid L, Hagberg G, Lundberg A. The effect of benzodiazepines on the fetus and the newborn. Neuropediatrics 1992;23(1):18-23.
11. Lewis PJ, Boylan P. Alcohol and fetal breathing. Lancet 1979;1 (8112):388.
12. Lingford-Hughes AR, Welch S, Nutt DJ, British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 2004;18(3):293-335. (Pubitemid 39382560)
13. Loebstein R, Koren G. Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience. [Review] [21 refs]. Journal of Psychiatry & Neuroscience 1997;22(3):192-196 (Pubitemid 27343427)
14. Maier SE, Chen WJ, Miller JA, West JR. Fetal alcohol exposure and temporal vulnerability regional differences in alcohol-induced microencephaly as a function of the timing of binge-like alcohol exposure during rat brain development. Alcoholism: Clinical & Experimental Research 1997;21(8):1418-1428
15. Matalon S, Schechtman S, Goldzweig G, Ornoy A. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reproductive Toxicology 2002;16(1):9-17. (Pubitemid 34308448)
16. Mattison D, Zajicek A. Gaps in knowledge in treating pregnant women. [Review] [31 refs]. Gender Medicine 2006;3(3):169-182
17. Mattson SN, Calarco KE, Lang AR. Focused and shifting attention in children with heavy prenatal alcohol exposure. Neuropsychology 2006;20(3):361-369 (Pubitemid 43886871)
18. Noland JS, Singer LT, Arendt RE, Minnes S, Short EJ, Bearer CF. Executive functioning in preschool-age children prenatally exposed to alcohol, cocaine, and marijuana. Alcoholism: Clinical & Experimental Research 2003;27(4):647-656 (Pubitemid 36460704)
19. Nora AH, Nora JJ, Blu J. Limb-reduction anomalies in infants born to disulfiram-treated alcoholic mothers. Lancet 1977;2(8039):664. (Pubitemid 8183127)
20. Ornoy A, Arnon J, Shechtman S, Moerman L, Lukashova I. Is benzodiazepine use during pregnancy really teratogenic?. Reproductive Toxicology 1998;12(5):511-515 (Pubitemid 29110867)
21. Ostrea EM Jr, Hernandez JD, Bielawski DM, Kan JM, Leonardo GM, Abela MB, et al.Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect?. Alcoholism: Clinical & Experimental Research 2006;30(7):1152-1159
22. Ramkisson R, Campbell M, Agius M. The clinical dilemma - prescribing in pregnancy. Psychiatria Danubina 2008;20(1):88-90.
23. Rayburn WF, Bogenschutz MP. Pharmacotherapy for pregnant women with addictions. [Review] [104 refs]. American Journal of Obstetrics & Gynecology 2004;191(6):1885-1897
24. Reitnauer PJ, Callanan NP, Farber RA, Aylsworth AS. Prenatal exposure to disulfiram implicated in the cause of malformations in discordant monozygotic twins. [Review] [35 refs]. Teratology 1997;56 (6):358-362
25. Rosenberg L, Mitchell AA, Parsells JL, Pashayan H, Louik C, Shapiro S. Lack of relation of oral clefts to diazepam use during pregnancy. New England Journal of Medicine 1983;309(21):1282-1285 (Pubitemid 14201583)
26. Ryberg U. Pregnancy, Neonatal Period and Substance Abuse. In: Berglund M, Thelander S, Jonsson E editor(s). Treating alcohol and drug abuse: An evidence based review.. Vol. 1, Weinheim, Germany: Wiley, 2003:Chp 10, 573-582.
27. Scanlon JW. Letter: Effect of benzodiazepines in neonates. New England Journal of Medicine 1975;292(12):649-650
28. Schottenfeld R S. Clinical trials of pharmacologic treatments in pregnant women - methodologic considerations.. NIDA-Research Monograph. Rockville, MD: NIH, 1995, issue 149-1995:201.
29. Stuppaeck CH, Pycha R, Miller C, Whitworth AB, Oberbauer H, Fleischhacker WW. Carbamazepine versus oxazepamin the treatment of alcohol withdrawal: a double-blind study. Alcohol & Alcoholism 1992;27(2):153-158
30. Vocci F. Overview: Medications Development for the Treatment of Drug Abuse. NIDA-Research Monograph. Rockville, MD: NIH, 1995, issue 149:4.
31. Vocci F, Ling W. Medications development: successes and challenges. Pharmacology & Therapeutics 2005;108(1):94-108.
32. Wozniak JR, Mueller BA, Chang PN, Muetzel RL, Caros L, Lim KO. Diffusion tensor imaging in children with fetal alcohol spectrum disorders. Alcoholism: Clinical & Experimental Research 2006;30 (10):1799-1806 (Pubitemid 44465619)
33. Wright A, Walker J. Drugs of abuse in pregnancy. [Review] [54 refs]. Best Practice & Research in Clinical Obstetrics& Gynaecology 2001;15 (6):987-998
34. AAP. American Academy of Pediatrics. Committee on substance abuse and committee on children with disabilities. Fetal alcohol syndrome and alcohol related neruodevelopmental disorders.. Pediatrics 2000;106:358-361
35. Barrison IG, Waterson EJ, Murray-Lyon IM. Adverse effects of alcohol in pregnancy. British Journal of Addiction 1985;80:11-22.
36. Belcher HM, Shapiro BK, Leppert M, Butz AM, Sellers S, Arch E, et al.Sequential neuromotor examination in children with intrauterine cocaine / polydrug exposure. Developmental Medicine and Children Neurology 1999;41(4):240-246 (Pubitemid 29209926)
37. Bessinger BA, Garland AF, Litrownik AJ, Landsverk JS. Caregiver substance abuse among maltreated children placed in out-of-home care. Child Welfare 1999;78:221-239
38. Doggett C, Burrett S, Osborn DA. Home visits during pregnancy and after birth for women with an alcohol or drug proble (Review). Cochrane Database of Systematic Reviews. 2006, 2005, issue 4.
39. Eriksson M, Jonsson B, Steneroth G, Zetterstrom R. Amphetamine abuse during pregnancy: environmental factors and outcomes after 14-15 years. Scandinavian Journal of Public Health 2000;28:154-157
40. Faden VB, Graubard BI. Maternal substance use during pregnancy and developmental outcomes at age three. Journal of substance Abuse Treatment 2000;12:329-340
41. Annomyous. Center for Drug Evaluation and Research, Label and History. US Food and Drug Administration Acessed Dec 15, 2007: www.fda.gov.
42. Frank DA, Augustyn M, Knight WG, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenat. JAMA 2001;285:1613-1625
43. Garbutt, James, West SL, Carey TS, Lohr KN, Crew FT. Pharmacological Treatment of Alcohol Dependence A Review of the Evidence. JAMA April 1999;281(14):1318-1325 (Pubitemid 29174484)
44. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration, 2008 [updated September 2008]; Vol.Available from www.cochrane-handbook.org..
45. International Center for Alcohol Policies. International Guidelines on Drinking and Pregnancy International Guidelines on Drinking during Pregnancy. Policy Issues, Drinking Guidelines October 15, 2007; Vol.www.icap.org.
46. Jacobson SW, Chiodo LM, Sokol RJ, Jacobson JL. Validity of maternal report of prenatal alcohol, cocaine and smoking relation to neurbehavioral outcomes. Pediatrics 2002;109:815-825
47. Jaffe, Jerone, Kranzler HR, Ciraulo DA. Drugs Used in theTreatment of Alcoholism. In: Mendelson, Jack H. Mello, Nancy K editor(s). Medical Diagnosis and Treatment of Alcoholism. New York: McGraw-Hill INC, 1992:421-462
48. Jaudes PK, Ekwo EE. Outcomes for infants exposed in utero to illict drugs. Child Welfare 1997;76:521-534
49. Kenna, George, McGeary John, Swift Robert. Pharmacotherapy, pharmacogenomics and the future of Alcohol Dependence, part 2. Am J Health-Syst Pharm 2004;61:2280-2288
50. Kenna, George, McGeary John, Swift Robert. Pharmacotherapy, pharmacogenomics and the future of alcohol dependence treatment, part 1. Am J Health-Syst Pharm 2004;61:2272-2279
51. Kranzler HR, VanKirk J. Efficacy of Naltrexone and Acamprostate for Alcoholism Treatment: AMeta-Analysis. Alcoholism:Clinical and Experimental Research September 2001;25(9):1335-1341
52. Lui S, Terplan M, Smith EJ. Psychosocial interventions for women enrolled in alcohol treatment during pregnancy. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD006753.pub2] (Pubitemid 351805350)
53. Mann, Karl. The Pharmacological Treatment of Alcohol Dependence: Needs and Possibilities. Alcohol & Alcoholism 1996;31(Suppl 1.):55-58 (Pubitemid 26150745)
54. Nair P, Black MM, Schuler M, Keane V, Snow L, Rigney BA, et al.Risk factors for disruption in primary caregiving among infants of substance abusing women. Child Abuse and Neglect 1997;21:1039-1051 (Pubitemid 27517742)
55. National Collaborating Centre for Womens and Children's Health. Antenatal care: routine care for the healthy pregnant woman. NICE clinical guideline 62 March 2008:18.
56. Substance Abuse and Mental Health Service Adminstration. Summary of findings from the 2006 National Survey on Drug Use & Health. Office of Applied Studies. Vol. NSDUH series, Rockville, MD: DHHS Publication, 2006:13.
57. Substance Abuse and Mental Health Service Administration. Results from the 2006 National Survey on Drug Use and Health:National Findings. Office of Applied Studies. NSDUH Series H-32, 3. Rockville, MD.: DHHS Publication No. SMA 07-429, 2007.
58. Olds DL, Robinson J, O'Brien R, Luckey DW, Pettitt LM, Henderson CR Jr, et al.Home visiting by paraprofessionals and by nurses: a randomised controlled trial. Pediatrics 2002;110:486-496 (Pubitemid 34976675)
59. National Statistics. Statistics on alcohol: England 2006. National Statistics 2006:39.
60. Pietrantoni M, Knuppel RA. Alcohol use in pregnancy. Clinical Perinatology 1991;18:93-111.
61. Raistrick D, Heather N, Godfrey C. Review of the effectiveness of treatment for alcohol problems. National Treatment Agency for Substance Misuse 2006.
62. Sanchez SM, Mize SG, Jiminez JM, Monroe BL, Rosenfield CR, Tyson JE. Systems approach to evaluation of maternal and neonatal care. 12th Hawaiian International Conference on System Sciences. 1979.
63. Singer LT, Arendt R, Minnes S, Farkas K, alvator A, Kirchner HL, et al.Cognitive andmotor outcomes of cocaine-exposed infants. JAMA 2002;287:1952-1960
64. Prime Minister's Strategy Unit. Alcohol Project : Interim Alaytical Report. Cabinet Office. London: UK Government, 2003.
65. Taylor DJ. Alcohol consumption and outcomes of pregnancy. Statement No. 5. Royal College of Obstricians and Gynaecologist. London, 2006.
66. Terplan M, Lui S. Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006037.pub2.] (Pubitemid 351805348)
67. TGA 2007. http://www.tga.gov.au/docs/html/medpreg.htm. Commonwealth of Australia 1999, Last Updated: 14 February 2007; Vol.Accessed: Dec 15, 2007.
68. Weintraub Z, Bental Y, Olivan A, Rotschild A. Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use. Addiction Biology 1998;2:159-170 (Pubitemid 28190958)